NCT06044961已完成不适用
Radiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 主要终点
- Use of radiomics
研究概览
简要总结
Identifying predictors of response to neoadjuvant therapy in gastric and gastro-oesophageal cancer early in the history of the disease would ensure optimal treatment planning.
The study aims to apply radiomics for the prediction of response to neoadjuvant therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with locally advanced stomach cancer undergoing neoadjuvant chemotherapy and gastrectomy between January 2005 and August 2022
排除标准
- •Siewert 1 tumors;
- •Patients who have received neoadjuvant with the addition of a biological drug;
- •Patients who have received radiotherapy;
- •Patients without staging CT scan or with insufficient image quality in terms of phases performed, pixel spacing, slide thickness (mandatorily: > 5 mm) or artefacts.
结局指标
主要结局
Use of radiomics
时间窗: 1 month
Apply radiomics for predicting response to neoadjuvant therapy.
次要结局
未报告次要终点
研究者
Agnes Annamaria
MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
相似试验
已完成
不适用
Using Radiomics to Predict Neoadjuvant Chemotherapy EfficacyGastric CancerNCT05465512Fujian Medical University193
Unknown
不适用
Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal CancerRectal CancerNCT04273477Sixth Affiliated Hospital, Sun Yat-sen University100
进行中（未招募）
不适用
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRIEsophageal NeoplasmsEsophageal CancerNCT04359732IRCCS San Raffaele121
已完成
不适用
OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaGastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal AdenocarcinomaGastric AdenocarcinomaEsophageal NeoplasmsNCT03429816University Hospital Heidelberg120
招募中
不适用
Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaNCT06642857Xiangdong Cheng150